Articles by Daniel Marsh
Pfizer Stock Rises on RBC Upgrade Despite German Drug-Pricing Threat
Pfizer shares rose 2.7% to $26.28 after RBC Capital upgraded the stock to Sector Perform, citing improved risk-reward. Meanwhile, a Reuters report flags German drug-pricing policy risks that could affect investments.
Theriva Biologics Surges on Phase 1 Cancer Data, But Risks Remain
TOVX surged 74.6% on Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump is not based on approval or revenue.
Trulieve Debuts on NYSE, Launches $50M Buyback Amid Policy Shifts
Trulieve started trading on the NYSE as TRLV, authorized a $50 million buyback, and closed its first day at $11.50. Investors eye liquidity gains amid cannabis rescheduling.
Propanc Biopharma Soars After Announcing $5M Stock Buyback
Propanc Biopharma shares skyrocketed after the company authorized a $5 million stock buyback, surpassing its entire market value. Investors now watch for progress on its cancer drug PRP.
Redwire Gains on $500M ATM Offering, Dilution Concerns Linger
Redwire shares jumped 8.3% Thursday after the company launched a $500 million ATM stock sale, raising $350 million already. Investors eye 2026 revenue target.
Mister Car Wash Exits Nasdaq After $3.1B LGP Buyout
Mister Car Wash (MCW) completed its $3.1 billion take-private by Leonard Green & Partners, delisting from Nasdaq and cashing out public shareholders at $7.00 per share.
Quantum Cyber Drops on Dilution Fears After Drone Filament Unit Reveal
Quantum Cyber shares slipped after unveiling plans for a drone filament division, as a $250 million shelf registration raised dilution concerns.
Grab Stock Nears 52-Week Low as Taiwan Foodpanda Deal Faces Scrutiny
Grab shares trade near a 52-week low of $3.26 as the $600 million foodpanda Taiwan deal awaits regulatory sign-off, despite strong Q1 growth.
UTime Shares Surge 48% Pre-Market on Financing Deal and Web3 Ambitions
UTime shares surged 48% in pre-market trading, driven by investor focus on a $50 million financing deal and the proposed Feixiaohao Web3 acquisition, despite dilution concerns.
D-Wave Quantum (QBTS) Plunges 50% from High as Revenue Concerns Mount
D-Wave Quantum shares fell 9% to $23.25, halving from their 52-week high, as investors question whether a 1,994% bookings surge can offset an 81% revenue decline.
Nu Holdings Stock Holds Steady Amid $1B Buyback, Analyst Downgrades
Nu Holdings shares steady near 52-week low after $1B buyback, but analyst downgrades on margin and credit concerns persist. CFO transition adds uncertainty.
AT&T Holds Gains as Fiber Strategy and Buyback Plan Buoy Outlook
AT&T shares held near Wednesday's close after the company reiterated its 2026 and multi-year guidance, including a $4.0-$4.5 billion Q2 free cash flow target and a fiber-driven growth plan.